13 results
8-K
MLYS
Mineralys Therapeutics Inc
10 Jun 24
Other Events
4:02pm
of the trial the assessment of automated office measured systolic BP from baseline for active cohorts versus placebo at six weeks, with the results pooled
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
, the audit committee reviews our policies with respect to risk assessment, risk management, including with respect to cybersecurity, loss prevention
S-3
EX-1.2
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
and no assessment in connection therewith has been made against the Company or any of its subsidiaries. The Company and its subsidiaries have filed all other tax … to any assessment received by the Company or any of its subsidiaries; except for such taxes, if any, as are being contested in good faith and as to which
8-K
EX-10.1
lgltg9x
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
10-Q
ddx76rsny6v5 151
15 May 23
Quarterly report
5:25pm
DRS/A
cp2 bvjp3
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
wzrpht7qj4wik0nwh
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
setp3eacohsa 5r5
4 Nov 22
Draft registration statement
12:00am
DRS
EX-4.2
xmoh7
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next